Abstract
With the development of precision oncology, a large number of clinical studies have confirmed the great potential of ctDNA in tumor management. However, the effectiveness and versatility of ctDNA detection are still questioned, which hinder the realization of clinical application of ctDNA detection, so there is an urgent need to develop unified quality control standards. The standardized pre-analytical processes for ctDNA analysis are the prerequisite to ensure the subsequent molecular detection. This paper will focus on the factors of quality control of pre-analytical processes for ctDNA analysis, in order to promote the standardized management of ctDNA detection. Key words: Circulating tumor DNA; Clinical laboratory techniques; Quality control
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
